Re­pub­li­can sen­a­tors slam pro­posed ac­cel­er­at­ed ap­proval pay­ment re­forms

Re­pub­li­can sen­a­tors are speak­ing out against a pro­posed test mod­el in which drug­mak­ers would ef­fec­tive­ly make less for drugs ap­proved via the FDA’s ac­cel­er­at­ed ap­proval …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER